A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

✍ Scribed by Shapiro, Geoffrey I.; McCallum, Stewart; Adams, Laurel M.; Sherman, Laurie; Weller, Steve; Swann, Suzanne; Keer, Harold; Miles, Dale; Müller, Thomas; LoRusso, Patricia

• Book ID: 121637901
• Publisher: Springer US
• Year: 2012
• Tongue: English
• Weight: 260 KB
• Volume: 31
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-012-9881-z